Gene signatures in the management of hepatocellular carcinoma.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Seminars in Oncology

• Publication date

  2012-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1053/j.seminoncol.2012.05.003PMID 22846864
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sixty‐five gene‐based risk score classifier predicts overall survival in hepatocellular carcinoma

  2012cited by this paper
• EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma.

  2012cited by this paper
• The genetic basis for cancer treatment decisions.

  2012cited by this paper
• Genome‐wide DNA methylation profiles in hepatocellular carcinoma

  2012cited by this paper
• EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma.

  2012cited by this paper
• Drug development and clinical trials—the path to an approved cancer drug

  2012cited by this paper
• Serum microRNA Biomarkers for Detection of Non-Small Cell Lung Cancer

  2012cited by this paper
• Prevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challenges.

  2012cited by this paper
• Dysregulation of Wnt/β-catenin signaling in gastrointestinal cancers.

  2012cited by this paper
• Integrated Analysis of Prognostic Gene Expression Profiles from Hepatitis B Virus-Positive Hepatocellular Carcinoma and Adjacent Liver Tissue

  2012cited by this paper
• Single-cell exome sequencing and monoclonal evolution of a JAK2-negative myeloproliferative neoplasm.

  2012cited by this paper
• Quantitative analysis of multiple methylated genes in plasma for the diagnosis and prognosis of hepatocellular carcinoma.

  2011cited by this paper
• Circulating MicroRNAs as Biomarkers for Hepatocellular Carcinoma

  2011cited by this paper
• Circulating MicroRNAs in Patients with Chronic Hepatitis C and Non-Alcoholic Fatty Liver Disease

  2011cited by this paper
• MicroRNA Profile Predicts Recurrence after Resection in Patients with Hepatocellular Carcinoma within the Milan Criteria

  2011cited by this paper
• Targeted therapies for hepatocellular carcinoma.

  2011cited by this paper
• Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma.

  2011cited by this paper
• miR-1254 and miR-574-5p: Serum-Based microRNA Biomarkers for Early-Stage Non-small Cell Lung Cancer

  2011cited by this paper
• Gene Signatures Derived from a c-MET-Driven Liver Cancer Mouse Model Predict Survival of Patients with Hepatocellular Carcinoma

  2011cited by this paper
• Management of hepatocellular carcinoma: An update

  2011cited by this paper
• Genetics: An 18-gene signature (ColoPrint®) for colon cancer prognosis

  2011cited by this paper
• Gene-expression signature of vascular invasion in hepatocellular carcinoma.

  2011cited by this paper
• Improving Validation Practices in “Omics” Research

  2011cited by this paper
• Serum MicroRNAs as Biomarkers for Hepatocellular Carcinoma in Chinese Patients with Chronic Hepatitis B Virus Infection

  2011cited by this paper
• Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma.

  2011cited by this paper
• Methylation Profile of Single Hepatocytes Derived from Hepatitis B Virus-Related Hepatocellular Carcinoma

  2011cited by this paper
• Hepatocellular carcinoma.

  2011cited by this paper
• Comparison of effect sizes associated with biomarkers reported in highly cited individual articles and in subsequent meta-analyses.

  2011cited by this paper
• CpG island methylator phenotype in plasma is associated with hepatocellular carcinoma prognosis.

  2011cited by this paper
• Circulating tumor cells: not all detected cells are bad and not all bad cells are detected.

  2011cited by this paper
• First Steps on a Long Road

  2011cited by this paper
• Circulating MicroRNAs, miR‐21, miR‐122, and miR‐223, in patients with hepatocellular carcinoma or chronic hepatitis

  2011cited by this paper
• Tumor stroma reaction‐related gene signature predicts clinical outcome in human hepatocellular carcinoma

  2011cited by this paper
• Isolation of Circulating Tumor Cells in Patients with Hepatocellular Carcinoma Using a Novel Cell Separation Strategy

  2011cited by this paper
• Human hepatic cancer stem cells are characterized by common stemness traits and diverse oncogenic pathways

  2011cited by this paper
• Quantitative methylation analysis of multiple genes using methylation-sensitive restriction enzyme-based quantitative PCR for the detection of hepatocellular carcinoma.

  2011cited by this paper
• Isolation of circulating tumor cells using a microvortex-generating herringbone-chip

  2010cited by this paper
• Nearest Template Prediction: A Single-Sample-Based Flexible Class Prediction with Confidence Assessment

  2010cited by this paper
• Gene expression in nontumoral liver tissue and recurrence-free survival in hepatitis C virus-positive hepatocellular carcinoma

  2010cited by this paper
• Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer

  2010cited by this paper
• A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients.

  2010cited by this paper
• Genomic tracing of the elusive liver cancer ancestor.

  2010cited by this paper
• Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma.

  2010cited by this paper
• New Strategies in Hepatocellular Carcinoma: Genomic Prognostic Markers

  2010cited by this paper
• Identification of a cholangiocarcinoma-like gene expression trait in hepatocellular carcinoma.

  2010cited by this paper
• Hepatocellular Carcinoma Displays Distinct DNA Methylation Signatures with Potential as Clinical Predictors

  2010cited by this paper
• The Road from Discovery to Clinical Diagnostics: Lessons Learned from the First FDA-Cleared In Vitro Diagnostic Multivariate Index Assay of Proteomic Biomarkers

  2010cited by this paper
• Plasma microRNAs as potential biomarkers for non-small-cell lung cancer

  2010cited by this paper
• ALK inhibition for non-small cell lung cancer: from discovery to therapy in record time.

  2010cited by this paper
• Molecular classification and novel targets in hepatocellular carcinoma: recent advancements.

  2010cited by this paper
• CpG Island Methylator Phenotype Associated with Tumor Recurrence in Tumor–Node–Metastasis Stage I Hepatocellular Carcinoma

  2010cited by this paper
• Concordance of DNA methylation pattern in plasma and tumor DNA of Egyptian hepatocellular carcinoma patients.

  2010cited by this paper
• Progenitor‐derived hepatocellular carcinoma model in the rat

  2010cited by this paper
• Circulating microRNAs, potential biomarkers for drug-induced liver injury

  2009cited by this paper
• Lin28 Enhances Tumorigenesis and is Associated With Advanced Human Malignancies

  2009cited by this paper
• Hepatocellular carcinoma in the Asia pacific region

  2009cited by this paper
• Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening

  2009cited by this paper
• A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma.

  2009cited by this paper
• Molecular prediction of early recurrence after resection of hepatocellular carcinoma.

  2009cited by this paper
• Use of archived specimens in evaluation of prognostic and predictive biomarkers.

  2009cited by this paper
• Molecular profiling to predict hepatocellular carcinoma outcome

  2009cited by this paper
• EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features.

  2009cited by this paper
• Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma.

  2009cited by this paper
• Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

  2009cited by this paper
• Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis.

  2009cited by this paper
• The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform.

  2009cited by this paper
• Molecular networks as sensors and drivers of common human diseases

  2009cited by this paper
• Circulating tumor cells: a useful predictor of treatment efficacy in metastatic breast cancer.

  2009cited by this paper
• Identification of noninvasive imaging surrogates for brain tumor gene-expression modules

  2008cited by this paper
• Gene expression in fixed tissues and outcome in hepatocellular carcinoma.

  2008cited by this paper
• Significance of CD90+ cancer stem cells in human liver cancer.

  2008cited by this paper
• EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma.

  2008cited by this paper
• Association of MicroRNA Expression in Hepatocellular Carcinomas with Hepatitis Infection, Cirrhosis, and Patient Survival

  2008cited by this paper
• Transforming growth factor‐β gene expression signature in mouse hepatocytes predicts clinical outcome in human cancer

  2008cited by this paper
• Clinical application of the 70-gene profile: the MINDACT trial.

  2008cited by this paper
• Development of the 21-gene assay and its application in clinical practice and clinical trials.

  2008cited by this paper
• Methylation of tumor associated genes in tissue and plasma samples from liver disease patients.

  2008cited by this paper
• Gene Expression–Based Recurrence Prediction of Hepatitis B Virus–Related Human Hepatocellular Carcinoma

  2008cited by this paper
• Focal gains of VEGFA and molecular classification of hepatocellular carcinoma.

  2008cited by this paper
• Variable DNA methylation patterns associated with progression of disease in hepatocellular carcinomas.

  2008cited by this paper
• Identification of metastasis‐related microRNAs in hepatocellular carcinoma

  2008cited by this paper
• The Use of Genomics in Clinical Trial Design

  2008cited by this paper
• Enabling personalized cancer medicine through analysis of gene-expression patterns

  2008cited by this paper
• Direct multiplexed measurement of gene expression with color-coded probe pairs

  2008cited by this paper
• Decoding global gene expression programs in liver cancer by noninvasive imaging

  2007cited by this paper
• Genetically distinct and clinically relevant classification of hepatocellular carcinoma: putative therapeutic targets.

  2007cited by this paper
• Gene Expression Profiling Reveals Potential Biomarkers of Human Hepatocellular Carcinoma

  2007cited by this paper
• Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma.

  2007cited by this paper
• Predicting Hepatocellular Carcinoma by Detection of Aberrant Promoter Methylation in Serum DNA

  2007cited by this paper
• Critical review of published microarray studies for cancer outcome and guidelines on statistical analysis and reporting.

  2007cited by this paper
• Isolation of rare circulating tumour cells in cancer patients by microchip technology

  2007cited by this paper
• Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets

  2007cited by this paper
• Identification and Validation of a Novel Gene Signature Associated with the Recurrence of Human Hepatocellular Carcinoma

  2007cited by this paper
• Differential effects of inactivated Axin1 and activated β-catenin mutations in human hepatocellular carcinomas

  2007cited by this paper
• Radiogenomic analysis to identify imaging phenotypes associated with drug response gene expression programs in hepatocellular carcinoma.

  2007cited by this paper
• Concordance among gene-expression-based predictors for breast cancer.

  2006cited by this paper
• Met-regulated expression signature defines a subset of human hepatocellular carcinomas with poor prognosis and aggressive phenotype.

  2006cited by this paper
• Uses and abuses of tumor markers in the diagnosis, monitoring, and treatment of primary and metastatic breast cancer.

  2006cited by this paper
• Detection of aberrant promoter methylation of GSTP1 in the tumor and serum of Chinese human primary hepatocellular carcinoma patients.

  2006cited by this paper
• A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis.

  2006cited by this paper

• A systematic review of MicroRNA (miRNA) biomarkers in the diagnosis and prognosis of hepatocellular carcinoma.

  2026cites this paper
• Cross talk between genetics and biochemistry in the pathogenesis of hepatocellular carcinoma

  2024cites this paper
• Unleashing the potential of gene signatures as prognostic and predictive tools: A step closer to personalized medicine in hepatocellular carcinoma (HCC)

  2024cites this paper
• Protein kinase C delta enhances the diagnostic performance of hepatocellular carcinoma

  2024cites this paper
• A prognostic model for hepatocellular carcinoma patients based on polyunsaturated fatty acid‐related genes

  2024cites this paper
• Hepatocellular Carcinoma Genetic Classification

  2023cites this paper
• E2F target score is associated with cell proliferation and survival of patients with hepatocellular carcinoma.

  2023cites this paper
• Polyunsaturated Fatty Acid–Bound α-Fetoprotein Promotes Immune Suppression by Altering Human Dendritic Cell Metabolism

  2023cites this paper
• A pyroptosis-related gene signature provides an alternative for predicting the prognosis of patients with hepatocellular carcinoma

  2023cites this paper
• Classification of Hepatocellular Carcinoma Based on N6-Methylandenosine–Related lncRNAs Profiling

  2022cites this paper
• Protein Kinase C Delta Is a Novel Biomarker for Hepatocellular Carcinoma

  2022cites this paper
• RNA sequencing analysis of hepatocellular carcinoma identified oxidative phosphorylation as a major pathologic feature

  2022influential citation
• Molecular classification of hepatocellular carcinoma: prognostic importance and clinical applications

  2021cites this paper
• Prognostic Cancer Gene Expression Signatures: Current Status and Challenges

  2021cites this paper
• International Liver Cancer Association (ILCA) White Paper on Biomarker Development for Hepatocellular Carcinoma.

  2021cites this paper
• Deep Learning Predicts Overall Survival of Patients With Unresectable Hepatocellular Carcinoma Treated by Transarterial Chemoembolization Plus Sorafenib

  2020cites this paper
• Biomarkers for Hepatobiliary Cancers

  2020influential citation
• Genetics of Hepatocellular Carcinoma: Approaches to Explore Molecular Diversity

  2020cites this paper
• Overexpression of CDCA5, KIF4A, TPX2, and FOXM1 Coregulated Cell Cycle and Promoted Hepatocellular Carcinoma Development

  2020cites this paper
• Serum Alpha-fetoprotein Levels and Clinical Outcomes in the Phase III CELESTIAL Study of Cabozantinib versus Placebo in Patients with Advanced Hepatocellular Carcinoma

  2020cites this paper
• Development and validation of a CTNNB1‐associated metabolic prognostic model for hepatocellular carcinoma

  2020cites this paper
• Hepatocellular carcinoma with non-B and non-C hepatitis origin: epidemiology in Japan and surgical outcome.

  2019cites this paper
• Gene signature predictive of hepatocellular carcinoma patient response to transarterial chemoembolization

  2019cites this paper
• Comprehensive analysis of transcriptome profiles in hepatocellular carcinoma

  2019cites this paper
• Ramucirumab as a second line therapy for advanced HCC: a significant achievement or a wasted opportunity for personalised therapy?

  2019cites this paper
• NELFE-Dependent MYC Signature Identifies a Unique Cancer Subtype in Hepatocellular Carcinoma

  2019cites this paper
• The role of albumin–bilirubin grade and inflammation-based index in patients with hepatocellular carcinoma treated with stereotactic body radiotherapy

  2018cites this paper
• Development Of A Three-Gene Prognostic Signature For Hepatitis B Virus Associated Hepatocellular Carcinoma Based On Integrated Transcriptomic Analysis

  2018cites this paper
• Investigation of the role of hepatic stellate cells in acute liver failure and hepatocarcinogenesis

  2017cites this paper
• Imaging-based surrogate markers of transcriptome subclasses and signatures in hepatocellular carcinoma: preliminary results

  2017cites this paper
• Systemic Inflammatory Response Is a Prognostic Marker in HIV-Infected Patients with Hepatocellular Carcinoma

  2017cites this paper
• Serum Wisteria Floribunda Agglutinin-Positive Sialylated Mucin 1 as a Marker of Progenitor/Biliary Features in Hepatocellular Carcinoma

  2017cites this paper
• The status of transarterial chemoembolization treatment in the era of precision oncology.

  2017cites this paper
• Tumor‐adjacent tissue co‐expression profile analysis reveals pro‐oncogenic ribosomal gene signature for prognosis of resectable hepatocellular carcinoma

  2017cites this paper
• Low levels of circulating microRNA-26a/29a as poor prognostic markers in patients with hepatocellular carcinoma who underwent curative treatment.

  2017cites this paper
• SALL 4 expression is associated with poor outcome in hepatocellular carcinoma

  2017cites this paper
• Diagnostic and Prognostic Performance of Liquid Biopsy in Hepatocellular Carcinoma

  2017cites this paper
• Genetics of Hepatocellular Carcinoma: Risk Stratification, Clinical Outcome, and Implications for Therapy

  2017cites this paper
• Expression and Clinical Significance of the Novel Long Noncoding RNA ZNF674-AS1 in Human Hepatocellular Carcinoma

  2016cites this paper
• Pathobiology of Hepatitis B Virus-Induced Carcinogenesis

  2016cites this paper
• Molecular pathological epidemiology in diabetes mellitus and risk of hepatocellular carcinoma

  2016cites this paper
• Nontumor Prognostic Factors in Hepatocellular Carcinoma

  2016cites this paper
• Epithelial-mesenchymal transition in gastroenterological cancer

  2015cites this paper
• Implementation of systems theory in liver cancer research.

  2015cites this paper
• Advances in targeted therapies for hepatocellular carcinoma in the genomic era

  2015cites this paper
• β-catenin alteration is rare in hepatocellular carcinoma with steatohepatitic features: immunohistochemical and mutational study

  2015cites this paper
• Multidisciplinary perspective of hepatocellular carcinoma: A Pacific Northwest experience.

  2015cites this paper
• Signaling in hepatocellular carcinoma

  2015cites this paper
• Blood Gene Signature for Early Hepatocellular Carcinoma Detection in Patients With Chronic Hepatitis B

  2015cites this paper
• Genetic Landscape and Biomarkers of Hepatocellular Carcinoma.

  2015cites this paper
• Predicting recurrence following radiofrequency percutaneous ablation for hepatocellular carcinoma.

  2014cites this paper
• DNA markers in molecular diagnostics for hepatocellular carcinoma

  2014cites this paper
• Hepatocellular carcinoma with steatohepatitic features: a clinicopathological study of Japanese patients

  2014cites this paper
• The biological and clinical challenge of liver cancer heterogeneity.

  2014cites this paper
• PREDICTING FACTORS OF RECURRENCE AFTER HCC TREATMENT Percutaneous

  2014cites this paper
• Tracking HCC pathogenesis but not the tumor cells after biopsy.

  2014cites this paper
• Prognostic factors for hepatocellular carcinoma recurrence.

  2014cites this paper
• Clinicopathologic characteristics of SALL4-immunopositive hepatocellular carcinoma

  2014cites this paper
• Molecular Determinants of Prognosis in Hepatocellular Carcinoma

  2014cites this paper
• Survival analysis tools in genomics research

  2014cites this paper
• Hepatic fibrosis and the microenvironment: fertile soil for hepatocellular carcinoma development.

  2014cites this paper
• Dynamic changes of the inflammation‐based index predict mortality following chemoembolisation for hepatocellular carcinoma: a prospective study

  2014cites this paper
• Efficacy of combination treatment modalities for intermediate and advanced hepatocellular carcinoma: intra-arterial therapies, sorafenib and novel small molecules.

  2013cites this paper
• Hepatocellular Carcinoma from an Immunologic Perspective

  2013cites this paper
• Prognostic Gene Signatures for Hepatocellular Carcinoma: What Are We Measuring?

  2013cites this paper
• Molecular Mechanisms of HBV-Associated Hepatocarcinogenesis

  2013cites this paper
• Genetically engineered mouse models: future tools to predict clinical trial results in oncology?

  2013cites this paper
• Lentivirus-delivered short hairpin RNA targeting SNAIL inhibits HepG2 cell growth.

  2013cites this paper
• FAM9C plays an anti-apoptotic role through activation of the PI3K/Akt pathway in human hepatocellular carcinoma.

  2013cites this paper
• A functional polymorphism in the epidermal growth factor gene predicts hepatocellular carcinoma risk in Japanese hepatitis C patients

  2013cites this paper
• Molecular epidemiology of hepatocellular carcinoma

  2012cites this paper